ALT · Forms 3, 4, 5

Insider trades at Altimmune, Inc.

1 insider bought $44K of Altimmune, Inc. stock on the open market in the last 90 days.

Every Form 3, 4 and 5 filed for Altimmune, Inc. (ALT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Richard Thomas MenziusoPrincipal Accounting OfficerOptions or other derivativesForm 4
Richard Thomas MenziusoPrincipal Accounting OfficerBecame an insider (Form 3)Form 3
Christophe Arbet-EngelsChief Medical OfficerOption exercise37,500Form 4
Christophe Arbet-EngelsChief Medical OfficerTax withholding12,679$2.76$35KForm 4
Gregory L WeaverChief Financial OfficerOption exercise14,475Form 4
Gregory L WeaverChief Financial OfficerTax withholding4,379$2.76$12KForm 4
Linda M RichardsonChief Commercial OfficerOption exercise24,000Form 4
Linda M RichardsonChief Commercial OfficerTax withholding6,826$3.24$22KForm 4
Jerome Benedict DursoPresident and CEOBuy15,000$2.95$44KForm 4
Gregory L WeaverChief Financial OfficerAward1,753$2.41$4KForm 4
M Scot RobertsChief Scientific OfficerAward875$2.41$2KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.